The challenge of adequate imaging surveillance in primary central nervous system lymphoma.

about

The challenge of adequate imaging surveillance in primary central nervous system lymphoma.

Item

http://www.wikidata.org/entity/Q52843442

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年学术文章

@wuu

2016年学术文章

@zh

2016年学术文章

@zh-cn

2016年学术文章

@zh-hans

2016年学术文章

@zh-my

2016年学术文章

@zh-sg

2016年學術文章

@yue

2016年學術文章

@zh-hant

name

The challenge of adequate imag ...... ntral nervous system lymphoma.

@en

The challenge of adequate imag ...... ntral nervous system lymphoma.

@nl

type

Item

label

The challenge of adequate imag ...... ntral nervous system lymphoma.

@en

The challenge of adequate imag ...... ntral nervous system lymphoma.

@nl

prefLabel

The challenge of adequate imag ...... ntral nervous system lymphoma.

@en

The challenge of adequate imag ...... ntral nervous system lymphoma.

@nl

P1476

The challenge of adequate imag ...... ntral nervous system lymphoma.

@en

P2093

Agnieszka Korfel

http://www.w3.org/2001/XMLSchema#string

Uwe Schlegel

http://www.w3.org/2001/XMLSchema#string

P2860

Patterns of response and relapse in primary CNS lymphomas after first-line chemotherapy: imaging analysis of the ANOCEF-GOELAMS prospective randomized trial.

Non-enhancing relapse of a primary CNS lymphoma with multiple diffusion-restricted lesions.

MR imaging features of intracranial primary CNS lymphoma in immune competent patients.

Report of an international workshop to standardize baseline evaluation and response criteria for primary CNS lymphoma.

Brain and whole-body FDG-PET in diagnosis, treatment monitoring and long-term follow-up of primary CNS lymphoma.

Diagnosis and treatment of primary CNS lymphoma.

Diagnosis and treatment of primary CNS lymphoma in immunocompetent patients: guidelines from the European Association for Neuro-Oncology.

Methotrexate and temozolomide versus methotrexate, procarbazine, vincristine, and cytarabine for primary CNS lymphoma in an elderly population: an intergroup ANOCEF-GOELAMS randomised phase 2 trial.

Primary CNS lymphoma at first relapse/progression: characteristics, management, and outcome of 256 patients from the French LOC network.

Primary central nervous system lymphomas (PCNSL): MRI features at presentation in 100 patients.

P304

307-308

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

editorial

P356

10.1093/NEUONC/NOW273

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2016-12-26T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28025387

http://www.w3.org/2001/XMLSchema#string

P932

5464301

http://www.w3.org/2001/XMLSchema#string